AboutMadeleine McDowell, MD, FAAP

Madeleine leverages a decade of clinical experience to leading the development and application of Sg2’s data analytic tools and providing clinical insight for all Sg2 research—service line, strategic planning, performance strategy and clinical technology. Her involvement with the annual updates of Sg2’s Impact of Change® forecasts and CARE Grouper ensures rigorous clinical oversight is applied.

Madeleine is a trusted advisor to many nationally recognized children’s hospitals and provides thought leadership to the women’s health and pediatrics intelligence teams. She is a frequent speaker at Sg2 educational events, executive leadership meetings, board retreats and industry conferences. In addition, Madeleine applies her clinical expertise to customized client engagements that utilize Sg2 Analytics for strategic planning, clinical integration, innovation and technology acquisition, care redesign optimization and facility planning.

Board certified in pediatrics, Madeleine spent more than 10 years in clinical practice, including serving as a hospitalist at Boston Children’s Hospital and a faculty member
of Harvard Medical School. She was a past clinical advisor for the Children’s Hospital Association and a keynote speaker at its annual meetings.

Madeleine received an MD from the University of Connecticut School of Medicine and completed her internship and residency in pediatrics at Yale-New Haven Hospital. Her civic duties include medical volunteer work for a community health center.

"Analytics and expertise to help you understand market dynamics and capitalize opportunities for growth."

As of February 11, 2016, Vizient, Inc. has completed its purchase of MedAssets Sg2 and spend and clinical resource management segments from Pamplona Capital Management, LLC. MedAssets revenue cycle business will continue to operate as a wholly-owned subsidiary of Pamplona Capital Management LLP.

Follow Sg2 on Facebook Follow Sg2 on Twitter Connect with Sg2 on LinkedIn Watch Sg2 on YouTube